FK-962

Known as: FK962 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2016
0120052016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
PURPOSES To establish the in silico ocular pharmacokinetic modeling for eye drops, and to simulate the dose regimen for FK962 in… (More)
Is this relevant?
2016
2016
Corneal sensation, cell proliferation, and wound healing all depend on adequate corneal innervation. Disruption of corneal… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2012
2012
PURPOSE Amputation of the trigeminal nerve leads to decreased corneal sensitivity and dry eye. Our previous study showed that the… (More)
Is this relevant?
2012
2012
PURPOSE To test if the drug FK962 (N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide) facilitates axonal elongation and recovery of… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
FK962 is a member of a novel class of compounds that promote somatostatin production in the brain, and is being developed as a… (More)
Is this relevant?
Review
2006
Review
2006
This review examines key pharmacological strategies that have been clinically studied for the primary or secondary prevention of… (More)
Is this relevant?
2005
2005
FK962 (N-(1-acetylpiperidin-4-yl)-4-fluorobenzamide) is a derivative of FK960 (N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide… (More)
Is this relevant?